Physician profile
Todd D Elftmann
NPI 1689751943
$12,531.18
in general payments reported to CMS, 2019-2025
4 companies · $3,214 in 2025
The $3,214 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $2,393 · 2021: $1,075 · 2022: $1,613 · 2023: $142 · 2024: $3,816 · 2025: $3,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,955 · Food and Beverage: $994 · Travel and Lodging: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,955.00 |
| Food and Beverage | $994.19 |
| Travel and Lodging | $222.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $8,642.50 | 2021-2025 | |
| Intuitive Surgical, INC. | $3,289.38 | 2019-2025 | |
| Medtronic, INC. | $565.93 | 2023-2024 | Venaseal, Pteye Parathyroid Detection System |
| Davol INC. | $33.37 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Elftmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.